Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients

Authors:

Abstract
Heterotopic ossification occurring after the use of commercially available bone morphogenetic proteins has not been widely reported. We describe four cases of heterotopic ossification in patients treated with either recombinant bone morphogenetic protein 2 or recombinant bone morphogenetic protein 7. We found that while some patients were asymptomatic, heterotopic ossification which had occurred around a joint often required operative excision with good results.

This publication has 55 references indexed in Scilit: